Moreover, LY3214996, the inhibitor of phosphorylated ERK1/2, obviously reduced the effect of NGF on the proliferation, migration, and invasion of colon cancer cells (Fig. S11C-H, S12). Here, MAPK3 is linked to malignant colon neoplasm.